Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06682494 · ClinicalTrials.gov registry record · NA

Enhancing Oral Cancer Awareness

A NA study of Oral Cancer and Prevention, sponsored by Virginia Commonwealth University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06682494 is a NA study of Oral Cancer and Prevention that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 60 participants, below the 210-participant average among 17 other Oral Cancer trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06682494, a NA study of Oral Cancer and Prevention, is actively recruiting participants, sponsored by Virginia Commonwealth University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

To evaluate the impact of AI-powered chatbot interactions versus traditional educational handouts on increasing participants' knowledge of oral cancer and its prevention

Interventions

  • BEHAVIORAL Traditional Education
  • BEHAVIORAL AI-powered Chatbox

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-09-24
Est. Completion 2026-10-31
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT06682494

The ClinicalTrials.gov registry entry for NCT06682494 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 210-participant average among 17 other Oral Cancer trials with a reported enrollment target (71% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Oral Cancer appearing as the primary indexed condition, and to 2 interventions - of which Traditional Education is the first listed.

NCT06682494 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT06682494 about?

NCT06682494 is a clinical study titled "Enhancing Oral Cancer Awareness". To evaluate the impact of AI-powered chatbot interactions versus traditional educational handouts on increasing participants' knowledge of oral cancer and its prevention

What is the current status of trial NCT06682494?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-09-24. Estimated completion is 2026-10-31.

What conditions does trial NCT06682494 study?

This clinical trial studies the following conditions: Oral Cancer, Prevention, Patient Education, Oropharyngeal Cancers, Chatbot.

What interventions are being tested in trial NCT06682494?

The interventions under investigation include: Traditional Education (BEHAVIORAL), AI-powered Chatbox (BEHAVIORAL).

Who is sponsoring clinical trial NCT06682494?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06682494 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Oral Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.